ABOVE: © ISTOCK.COM, SUDOK1
The US Food and Drug Administration is warning those who would seek infusions of young blood to ward off the afflictions of aging to not buy into the hype, according to a statement from Commissioner Scott Gottlieb yesterday (February 19).
The agency cautions that plasma, the liquid part of blood, from young individuals has “no proven clinical benefit” to treat or prevent the conditions of normal aging or associated diseases including dementia, Parkinson’s, Alzheimer’s, heart disease, or multiple sclerosis—despite what some clinics claim.
The FDA statement voices concerns about the unproven treatments, but doesn’t name any companies. “Simply put, we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies,” says the statement. The FDA warns that although “bad actors” may be charging thousands of dollars for the treatments, they come with significant risks ...
